Novartis AG Noncurrent Financial Assets
Novartis AG (NVS) had Noncurrent Financial Assets of $2.35 billion as of 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:NoncurrentFinancialAssets · last filed 2026-02-04
- 2025-12-31: Noncurrent Financial Assets $2.35B.
- 2025-06-30: Noncurrent Financial Assets $2.07B.
- 2024-12-31: Noncurrent Financial Assets $2.02B.
- 2024-06-30: Noncurrent Financial Assets $2.02B.
| Period end | Noncurrent Financial Assets |
|---|---|
| 2025-12-31 | $2.35B 20-F · filed 2026-02-04 |
| 2025-06-30 | $2.07B 6-K · filed 2025-07-17 |
| 2024-12-31 | $2.02B 20-F · filed 2026-02-04 |
| 2024-06-30 | $2.02B 6-K · filed 2024-07-18 |
| 2023-12-31 | $2.61B 20-F · filed 2025-01-31 |
| 2023-06-30 | $2.31B 6-K · filed 2023-07-18 |
| 2022-12-31 | $2.41B 20-F · filed 2024-01-31 |
| 2022-06-30 | $2.41B 6-K · filed 2022-07-19 |
| 2021-12-31 | $3.04B 20-F/A · filed 2023-05-15 |
| 2021-06-30 | $2.89B 6-K · filed 2021-07-21 |
| 2020-12-31 | $2.90B 20-F · filed 2022-02-02 |
| 2020-06-30 | $2.48B 6-K · filed 2020-07-21 |
| 2019-12-31 | $2.52B 20-F · filed 2021-01-26 |
| 2019-06-30 | $3.43B 6-K · filed 2019-07-18 |
| 2018-12-31 | $2.35B 20-F · filed 2020-01-29 |
| 2018-06-30 | $2.41B 6-K · filed 2018-07-18 |
| 2017-12-31 | $2.24B 20-F · filed 2019-01-30 |
| 2016-12-31 | $2.20B 6-K · filed 2018-01-24 |